Subcutaneous gentamicin injection around the cuff in treatment of resistant exit site infection in peritoneal dialysis patients: a pilot study

被引:1
作者
Dizdar, Oguzhan Sitki [1 ]
Ozer, Ozerhan [2 ]
Erdem, Selahattin [2 ]
Gunal, Ali Ihsan [3 ]
机构
[1] Kayseri Training & Res Hosp, Dept Internal Med & Clin Nutr, Kayseri, Turkey
[2] Kayseri Training & Res Hosp, Dept Internal Med, Kayseri, Turkey
[3] Kayseri Training & Res Hosp, Dept Internal Med, Div Nephrol, Kayseri, Turkey
来源
THERAPEUTICS AND CLINICAL RISK MANAGEMENT | 2017年 / 13卷
关键词
peritoneal dialysis; subcutaneous gentamicin; local treatment; catheter; efficacy; MUPIROCIN; MORTALITY; PREVENTION; THERAPY; TRIAL; RATES; CREAM;
D O I
10.2147/TCRM.S140894
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background/purpose: One of the most common complications of the peritoneal dialysis (PD) is the infection of the exit site of the peritoneal catheter. The aim of the present study was to evaluate the efficacy of the subcutaneous gentamicin injection around the cuff as a part of routine treatment of the resistant exit site infection (ESI). Methods: If the exit site remains infected after a 2-week systemic antibiotics treatment, it is defined as resistant ESI. In these cases, systemic antibiotics were discontinued and a subcutaneous 40-mg gentamicin injection was administered around the external cuff of the PD catheter every 3 days. A total of three or four injections were given to each patient. Results: A subcutaneous gentamicin injection was administered around the cuff in thirteen patients for the treatment of resistant ESI over a 2-year period. The median follow-up time in cured patients was 12 months. Eleven of the thirteen patients had been apparently cured of their resistant ESI, with no recurrence. None of the patients had a gentamicin-resistant species. Subcutaneous gentamicin-related adverse effect was not observed in any patient. Conclusion: Subcutaneous gentamicin injection around the cuff is a well-tolerated and effective strategy for treating resistant ESI. To gain widespread approval of this therapy and reach a consensus about ESI management, additional studies are needed.
引用
收藏
页码:909 / 914
页数:6
相关论文
共 27 条
  • [1] ABRAHAM G, 1988, PERITON DIALYSIS INT, V8, P211
  • [2] A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin
    Bernardini, J
    Piraino, B
    Holley, J
    Johnston, JR
    Lutes, R
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (05) : 695 - 700
  • [3] Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients
    Bernardini, J
    Bender, F
    Florio, T
    Sloand, J
    PalmMontalbano, L
    Fried, L
    Piraino, B
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (02): : 539 - 545
  • [4] Pseudomonas exit-site infection: treatment outcomes with topical gentamicin in addition to systemic antibiotics
    Burkhalter, Felix
    Clemenger, Michelle
    San Haddoub, San
    McGrory, Jacqueline
    Hisole, Nora
    Brown, Edwina
    [J]. CLINICAL KIDNEY JOURNAL, 2015, 8 (06): : 781 - 784
  • [5] THERAPY FOR STAPHYLOCOCCAL INFECTION
    CAFFERKEY, MT
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 1991, 4 (06) : 757 - 763
  • [6] DUCKWORTH G, 1990, J HOSP INFECT, V16, P351
  • [7] EYKYN SJ, 1988, LANCET, V1, P100
  • [8] Hemodialysis versus peritoneal dialysis: A comparison of adjusted mortality rates
    Fenton, SSA
    Schaubel, DE
    Desmeules, M
    Morrison, HI
    Mao, Y
    Copleston, P
    Jeffery, JR
    Kjellstrand, CM
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (03) : 334 - 342
  • [9] Hospitalization in peritoneal dialysis patients
    Fried, L
    Abidi, S
    Bernardini, J
    Johnston, JR
    Piraino, B
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (05) : 927 - 933
  • [10] Fried LF, 1996, J AM SOC NEPHROL, V7, P2176